The trader consensus for "No" at 76.5% implied probability stems from the current absence of any CDC Level 4 Travel Health Notices, which signal extreme health risks with no available precautions and apply only under exceptional conditions such as uncontrolled outbreaks. As of early June 2026, CDC monitoring shows recent Ebola Bundibugyo virus notices in the Democratic Republic of the Congo and Uganda limited to Level 3 (Reconsider Nonessential Travel), alongside lower-level alerts for chikungunya and malaria. These reflect contained transmission dynamics and official thresholds not yet met for escalation, consistent with historical patterns where Level 4 requires widespread, unpreventable threats. Ongoing CDC surveillance and model updates through year-end will determine any shift.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日はい
$71,851 Vol.
$71,851 Vol.
2026/12/31
はい
$71,851 Vol.
$71,851 Vol.
2026/12/31
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.The trader consensus for "No" at 76.5% implied probability stems from the current absence of any CDC Level 4 Travel Health Notices, which signal extreme health risks with no available precautions and apply only under exceptional conditions such as uncontrolled outbreaks. As of early June 2026, CDC monitoring shows recent Ebola Bundibugyo virus notices in the Democratic Republic of the Congo and Uganda limited to Level 3 (Reconsider Nonessential Travel), alongside lower-level alerts for chikungunya and malaria. These reflect contained transmission dynamics and official thresholds not yet met for escalation, consistent with historical patterns where Level 4 requires widespread, unpreventable threats. Ongoing CDC surveillance and model updates through year-end will determine any shift.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
マーケット開始日： Jan 19, 2026, 3:15 PM ET
音量
$71,851終了日
2026/12/31マーケット開始日
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.The trader consensus for "No" at 76.5% implied probability stems from the current absence of any CDC Level 4 Travel Health Notices, which signal extreme health risks with no available precautions and apply only under exceptional conditions such as uncontrolled outbreaks. As of early June 2026, CDC monitoring shows recent Ebola Bundibugyo virus notices in the Democratic Republic of the Congo and Uganda limited to Level 3 (Reconsider Nonessential Travel), alongside lower-level alerts for chikungunya and malaria. These reflect contained transmission dynamics and official thresholds not yet met for escalation, consistent with historical patterns where Level 4 requires widespread, unpreventable threats. Ongoing CDC surveillance and model updates through year-end will determine any shift.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
音量
$71,851終了日
2026/12/31マーケット開始日
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...The trader consensus for "No" at 76.5% implied probability stems from the current absence of any CDC Level 4 Travel Health Notices, which signal extreme health risks with no available precautions and apply only under exceptional conditions such as uncontrolled outbreaks. As of early June 2026, CDC monitoring shows recent Ebola Bundibugyo virus notices in the Democratic Republic of the Congo and Uganda limited to Level 3 (Reconsider Nonessential Travel), alongside lower-level alerts for chikungunya and malaria. These reflect contained transmission dynamics and official thresholds not yet met for escalation, consistent with historical patterns where Level 4 requires widespread, unpreventable threats. Ongoing CDC surveillance and model updates through year-end will determine any shift.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日
外部リンクに注意してください。
外部リンクに注意してください。
よくある質問